Medy-Tox Inc. (KOSDAQ: 086900)

Medy-Tox Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	27,651	33,246	20,688	71,777	43,993	20,017
Short-Term Investments	50	98.91	3,000	10,150	11,621	3,500
Trading Asset Securities	-	-	2,520	-	-	-
Cash & Short-Term Investments	27,701	33,345	26,208	81,927	55,614	23,517
Cash Growth	-31.39%	27.23%	-68.01%	47.31%	136.49%	-7.35%
Accounts Receivable	58,062	60,508	44,998	28,703	34,165	56,487
Other Receivables	2,450	6,139	6,485	12,057	5,224	2,002
Receivables	60,917	67,502	53,302	43,523	42,165	61,270
Inventory	64,421	59,618	52,620	32,971	37,555	29,332
Prepaid Expenses	-	2,892	1,866	966.57	1,630	1,202
Other Current Assets	8,203	2,875	1,138	1,571	1,747	4,708
Total Current Assets	161,243	166,232	135,134	160,959	138,711	120,030
Property, Plant & Equipment	201,419	205,262	208,878	205,531	214,007	187,243
Long-Term Investments	133,033	113,576	155,410	122,377	24,081	28,714
Goodwill	-	-	-	808.49	-	711.12
Other Intangible Assets	5,857	4,730	4,412	4,689	14,060	14,777
Long-Term Deferred Tax Assets	14,644	17,973	14,267	18,187	21,238	10,596
Long-Term Deferred Charges	53,547	49,490	22,058	6,308	3,893	6,815
Other Long-Term Assets	54,555	53,000	55,324	58,766	51,638	52,499
Total Assets	625,494	611,623	596,288	577,698	467,764	421,530
Accounts Payable	4,304	3,749	3,390	4,028	3,994	4,096
Accrued Expenses	2,877	7,118	9,389	1,554	1,971	2,106
Short-Term Debt	60,913	61,079	95,103	64,964	81,279	101,497
Current Portion of Long-Term Debt	20,000	20,000	5,012	12,000	-	-
Current Portion of Leases	577.14	525.21	411.35	571.91	558.87	391.44
Current Income Taxes Payable	1,472	7,982	7,993	13,861	1.13	1,206
Current Unearned Revenue	4.47	-	-	361.68	361.68	361.68
Other Current Liabilities	28,855	26,103	13,964	10,606	29,424	26,689
Total Current Liabilities	119,002	126,556	135,262	107,947	117,590	136,348
Long-Term Debt	-	-	20,000	55,057	65,263	177.84
Long-Term Leases	-	1,226	335.95	324.74	309.67	371.36
Long-Term Unearned Revenue	-	-	-	1,296	1,658	2,019
Long-Term Deferred Tax Liabilities	734.07	229.31	818.57	505.65	943.57	-
Other Long-Term Liabilities	6,718	8,998	6,256	8,062	34,809	17,311
Total Liabilities	126,917	137,141	162,673	174,134	222,962	158,849
Common Stock	3,649	3,649	3,331	3,127	2,989	2,908
Additional Paid-In Capital	147,963	148,037	112,896	113,978	48,688	23,622
Retained Earnings	419,513	406,665	401,111	364,112	268,147	304,574
Treasury Stock	-96,809	-96,921	-106,229	-89,296	-81,171	-70,873
Comprehensive Income & Other	18,884	7,813	16,693	7,288	2,676	-1,083
Total Common Equity	493,201	469,242	427,802	399,208	241,328	259,148
Minority Interest	5,156	5,020	5,571	4,084	3,405	3,533
Shareholders' Equity	498,577	474,482	433,616	403,565	244,802	262,681
Total Liabilities & Equity	625,494	611,623	596,288	577,698	467,764	421,530
Total Debt	81,490	82,830	120,862	132,917	147,410	102,438
Net Cash (Debt)	-53,789	-49,485	-94,654	-50,990	-91,796	-78,921
Net Cash Per Share	-8069.23	-7389.19	-14418.99	-7944.34	-14307.35	-12199.51
Filing Date Shares Outstanding	6.73	6.73	6.04	6.06	6.11	6.27
Total Common Shares Outstanding	6.73	6.73	6.34	6.36	6.41	6.45
Working Capital	42,241	39,676	-128.34	53,012	21,121	-16,318
Book Value Per Share	73269.88	69721.64	67506.12	62787.02	37638.40	40159.25
Tangible Book Value	487,344	464,512	423,390	393,711	227,268	243,660
Tangible Book Value Per Share	72399.75	69018.83	66809.98	61922.46	35445.54	37759.15
Land	49,514	49,514	49,514	46,032	50,466	48,427
Buildings	76,173	94,122	74,039	73,053	73,723	73,370
Machinery	4,907	28,021	26,103	24,476	22,737	21,762
Construction In Progress	11,919	14,218	71,941	64,047	56,978	21,342

Source: S&P Capital IQ. Standard template. Financial Sources.